[1]
W. Chuemongkon, K. Boonruang, and K. Tumpoo, “Aspirin Use for the Primary Prevention of Cardiovascular Diseases in Type 2 Diabetic Patients”, SRIMEDJ, vol. 34, no. 2, pp. 184–189, Apr. 2019.